Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 1;34(9):1469-1480.
doi: 10.1093/ndt/gfz089.

Nephrology and Public Policy Committee propositions to stimulate research collaboration in adults and children in Europe

Ziad A Massy  1   2 , Fergus J Caskey  3 , Patrik Finne  4   5 , Jerome Harambat  6 , Kitty J Jager  7 , Evi Nagler  8 , Benedicte Stengel  2 , Mehmet Sukru Sever  9 , Raymond Vanholder  10 , Peter J Blankestijn  11 , Annette Bruchfeld  12 , Giovambattista Capasso  13 , Danilo Fliser  14 , Denis Fouque  15 , Dimitrios Goumenos  16 , Maria Jose Soler  17   18 , Ivan Rychlík  19 , Goce Spasovski  20 , Kathryn Stevens  21 , Christoph Wanner  22 , Carmine Zoccali  23
Affiliations

Nephrology and Public Policy Committee propositions to stimulate research collaboration in adults and children in Europe

Ziad A Massy et al. Nephrol Dial Transplant. .

Erratum in

Abstract

The strengths and the limitations of research activities currently present in Europe are explored in order to outline how to proceed in the near future. Epidemiological and clinical research and public policy in Europe are generally considered to be comprehensive and successful, and the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) is playing a key role in the field of nephrology research. The Nephrology and Public Policy Committee (NPPC) aims to improve the current situation and translation into public policy by planning eight research topics to be supported in the coming 5 years by ERA-EDTA.

Keywords: acute kidney injury; big data; cohorts; guidelines; registry.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Roadmap for ongoing nephrology research for screening, diagnosing, preventing and treating CKD. Although valuable registry data and cohort studies exist for defining the current burden of CKD, novel studies are certainly needed for screening, diagnosing, preventing and treating this public health problem. Information that may be gained from future research may be useful for establishing novel predictive biomarkers for screening and diagnosing CKD, and thus be useful for creating/implementing guidelines and finally performing interventions for prevention and treatment of CKD. National societies, kidney foundations, ERA-EDTA and EKHA may collaborate and support all parties involved in managing the problems encountered during the planning and the support of these projects.
See this image and copyright information in PMC

References

    1. Zoccali C, Arici M, Blankestijn PJ. et al. The ERA-EDTA today and tomorrow: a progress document by the ERA-EDTA Council. Nephrol Dial Transplant 2018; 33: 1077–1082 - PubMed
    1. Schaeffner ES, van der Giet M, Gaedeke J. et al. The Berlin initiative study: the methodology of exploring kidney function in the elderly by combining a longitudinal and cross-sectional approach. Eur J Epidemiol 2010; 25: 203–210 - PubMed
    1. Raum E, Rothenbacher D, Low M. et al. Changes of cardiovascular risk factors and their implications in subsequent birth cohorts of older adults in Germany: a life course approach. Eur J Cardiovasc Prev Rehabil 2007; 14: 809–814 - PubMed
    1. Cirillo M, Terradura-Vagnarelli O, Mancini M. et al. Cohort profile: The Gubbio Population Study. Int J Epidemiol 2014; 43: 713–720 - PMC - PubMed
    1. Diercks GF, Janssen WM, van Boven AJ. et al. Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vascular ENdstage Disease Intervention Trial [PREVEND IT]). Am J Cardiol 2000; 86: 635–638 - PubMed